Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5387 ARTÍCULOS , VIENDO DEL 3901 AL 3915

Concurrent neuromechanical and functional gains following upper-extremity power training post-stroke

Patten C, Condliffe EG, Dairaghi CA, Lum PS.

J Neuroeng Rehabil. 2013 Jan 21;10:1. doi: 10.1186/1743-0003-10-1.

Your client has multiple sclerosis: understanding the challenge

Turkoski B.

Orthop Nurs. 2013 Jan-Feb;32(1):45-50; quiz 51-2. doi: 10.1097/NOR.0b013e31827d9799.

Novel hypomyelinating leukoencephalopathy affecting early myelinating structures: clinical course in two brothers

Tonduti D, Pichiecchio A, Wolf NI, Ariaudo G, van der Knaap MS, Bastianello S, Balottin U, Orcesi S.

Neuropediatrics. 2013 Aug;44(4):213-7. doi: 10.1055/s-0032-1333440. Epub 2013 Jan 24.

Multidisciplinary staged surgical management of bifrontal meningoencephalocele with long-term follow-up

Blount JP, Gordon AS, Foreman PM, Grant JH.

J Neurosurg Pediatr. 2013 Apr;11(4):478-84. doi: 10.3171/2012.11.PEDS12330. Epub 2013 Jan 25.

Modulation of the intrinsic properties of motoneurons by serotonin

Perrier JF, Rasmussen HB, Christensen RK, Petersen AV.

Curr Pharm Des. 2013;19(24):4371-84. doi: 10.2174/13816128113199990341.

[Importance and treatment of spasticity in multiple sclerosis : results of the MOVE 1 study]

Henze T, Flachenecker P, Zettl UK.

Nervenarzt. 2013 Feb;84(2):214-22. doi: 10.1007/s00115-012-3724-1.

Clinical utility of different botulinum neurotoxin preparations

Abrams SB, Hallett M.

Toxicon. 2013 Jun 1;67:81-6. doi: 10.1016/j.toxicon.2012.11.024. Epub 2013 Jan 30.

C4-C5 post-traumatic spondyloptosis with in situ fusion: systematic literature review and case report

Gasco J, Dilorenzo DJ, Patterson JT.

Spine (Phila Pa 1976). 2013 May 1;38(10):E621-5. doi: 10.1097/BRS.0b013e31828a32b4.

The pharmacologic and clinical effects of medical cannabis

Borgelt LM, Franson KL, Nussbaum AM, Wang GS.

Pharmacotherapy. 2013 Feb;33(2):195-209. doi: 10.1002/phar.1187.

Multiple sclerosis spasticity daily management: retrospective data from Europe

Berger T.

Expert Rev Neurother. 2013 Feb;13(3 Suppl 1):3-7. doi: 10.1586/ern.13.3.

Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain

García-Merino A.

Expert Rev Neurother. 2013 Feb;13(3 Suppl 1):9-13. doi: 10.1586/ern.13.4.

A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost-effectiveness in Germany

Flachenecker P.

Expert Rev Neurother. 2013 Feb;13(3 Suppl 1):15-9. doi: 10.1586/ern.13.1.

Multiple sclerosis spasticity: 'state-of-the-art' questionnaire survey of specialized healthcare professionals

Collongues N, Vermersch P.

Expert Rev Neurother. 2013 Feb;13(3 Suppl 1):21-5. doi: 10.1586/ern.13.10.

Solitary thoracic vertebral body cysticercosis presenting with progressive compressive myelopathy

Furtado SV, Dadlani R, Ghosal N, Rao AS.

J Neurosurg Spine. 2013 Apr;18(4):394-7. doi: 10.3171/2013.1.SPINE12675. Epub 2013 Feb 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias